257 related articles for article (PubMed ID: 23178653)
1. Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?
Mullane K; Williams M
Biochem Pharmacol; 2013 Feb; 85(3):289-305. PubMed ID: 23178653
[TBL] [Abstract][Full Text] [Related]
2. Progress in Alzheimer's disease drug discovery: an update.
Williams M
Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
4. The development of new therapeutics for Alzheimer's disease.
Carter MD; Simms GA; Weaver DF
Clin Pharmacol Ther; 2010 Oct; 88(4):475-86. PubMed ID: 20811351
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
Saxena U
Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic agents against Alzheimer's disease from natural sources.
Park SY
Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease (AD) therapeutics - 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality.
Mullane K; Williams M
Biochem Pharmacol; 2018 Dec; 158():359-375. PubMed ID: 30273553
[TBL] [Abstract][Full Text] [Related]
9. Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's disease.
Asai M; Iwata N; Tomita T; Iwatsubo T; Ishiura S; Saido TC; Maruyama K
J Neurosci Res; 2010 Dec; 88(16):3588-97. PubMed ID: 20890992
[TBL] [Abstract][Full Text] [Related]
10. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
11. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
12. Beyond amyloid: the future of therapeutics for Alzheimer's disease.
Lane RF; Shineman DW; Steele JW; Lee LB; Fillit HM
Adv Pharmacol; 2012; 64():213-71. PubMed ID: 22840749
[TBL] [Abstract][Full Text] [Related]
13. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Hardy J; Selkoe DJ
Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
[TBL] [Abstract][Full Text] [Related]
14. Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future.
Hampel H; Schneider LS; Giacobini E; Kivipelto M; Sindi S; Dubois B; Broich K; Nisticò R; Aisen PS; Lista S
Expert Rev Neurother; 2015 Jan; 15(1):83-105. PubMed ID: 25537424
[TBL] [Abstract][Full Text] [Related]
15. The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease.
Ling S; Zhou J; Rudd JA; Hu Z; Fang M
Anat Rec (Hoboken); 2011 Aug; 294(8):1307-18. PubMed ID: 21717585
[TBL] [Abstract][Full Text] [Related]
16. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
17. Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application.
Pietrzik C; Behl C
Int J Exp Pathol; 2005 Jun; 86(3):173-85. PubMed ID: 15910551
[TBL] [Abstract][Full Text] [Related]
18. Amyloid inhibitors and Alzheimer's disease.
Xia W
Curr Opin Investig Drugs; 2003 Jan; 4(1):55-9. PubMed ID: 12625030
[TBL] [Abstract][Full Text] [Related]
19. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?
Verdile G; Fuller S; Atwood CS; Laws SM; Gandy SE; Martins RN
Pharmacol Res; 2004 Oct; 50(4):397-409. PubMed ID: 15304237
[TBL] [Abstract][Full Text] [Related]
20. [Gamma-secretase inhibitors in Alzheimer's disease therapy].
Katarína S; Jan K; Kamil K; Kamil M
Ceska Slov Farm; 2012 Jun; 61(3):93-100. PubMed ID: 22913824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
